Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Neuropsychologia|February 17, 2007
Verbal episodic memory declines prior to diagnosis in Huntington's diseaseAndrea C Solomon, Julie C Stout, Shannon A Johnson, et al.
Human Molecular Genetics|April 4, 2020
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's diseaseMali Jiang, Xiaoyan Zhang, Hongshuai Liu, et al.
Neuroimage. Clinical|November 2, 2013
Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRIYuan-Yuan Qin, Johnny T Hsu, Shoko Yoshida, et al.
Nature Communications|June 9, 2016
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1Frederick C Nucifora, Leslie G Nucifora, Chee-Hoe Ng, et al.
Brain : a Journal of Neurology|June 23, 2007
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's diseaseShannon A Johnson, Julie C Stout, Andrea C Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2013
Targeting H3K4 trimethylation in Huntington diseaseMalini Vashishtha, Christopher W Ng, Ferah Yildirim, et al.
Science Translational Medicine|December 8, 2017
PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasisAudrey S Dickey, Dafne N Sanchez, Martin Arreola, et al.
Nature Communications|March 4, 2021
Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutationNam-Shik Kim, Zhexing Wen, Jing Liu, et al.
Nature Communications|May 1, 2021
Author Correction: Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutationNam-Shik Kim, Zhexing Wen, Jing Liu, et al.
Annals of Neurology|October 7, 2004
Huntington's Disease-like 2 (HDL2) in North America and JapanRussell L Margolis, Susan E Holmes, Adam Rosenblatt, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Neuropsychologia|February 17, 2007
Verbal episodic memory declines prior to diagnosis in Huntington's diseaseAndrea C Solomon, Julie C Stout, Shannon A Johnson, et al.
Human Molecular Genetics|April 4, 2020
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's diseaseMali Jiang, Xiaoyan Zhang, Hongshuai Liu, et al.
Neuroimage. Clinical|November 2, 2013
Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRIYuan-Yuan Qin, Johnny T Hsu, Shoko Yoshida, et al.
Nature Communications|June 9, 2016
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1Frederick C Nucifora, Leslie G Nucifora, Chee-Hoe Ng, et al.
Brain : a Journal of Neurology|June 23, 2007
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's diseaseShannon A Johnson, Julie C Stout, Andrea C Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2013
Targeting H3K4 trimethylation in Huntington diseaseMalini Vashishtha, Christopher W Ng, Ferah Yildirim, et al.
Science Translational Medicine|December 8, 2017
PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasisAudrey S Dickey, Dafne N Sanchez, Martin Arreola, et al.
Nature Communications|March 4, 2021
Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutationNam-Shik Kim, Zhexing Wen, Jing Liu, et al.
Nature Communications|May 1, 2021
Author Correction: Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutationNam-Shik Kim, Zhexing Wen, Jing Liu, et al.
Annals of Neurology|October 7, 2004
Huntington's Disease-like 2 (HDL2) in North America and JapanRussell L Margolis, Susan E Holmes, Adam Rosenblatt, et al.
Pageof 25